Quince Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $1.57 | $1.57 | $1.57 |
Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Quince Therapeutics, Inc. Earnings Date And Information
Quince Therapeutics, Inc. last posted its earnings results on Wednesday, November 9th, 2022. The company reported $-0.22 earnings per share for the quarter, topping analysts' consensus estimates of $-0.28 by $0.06. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Quince Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.84 diluted earnings per share) and currently has a price-to-earnings ratio of -0.64. Quince Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Quince Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/13/2024 | Q2 2024 | -$0.64 | $0 | $0 | ||
05/13/2024 | Q1 2024 | -$0.26 | $0 | $0 | ||
04/01/2024 | Q4 2023 | -$0.22 | $0 | $36,000 | ||
09/29/2023 | Q3 2023 | -$0.15 | $0 | $0 | ||
08/03/2023 | Q2 2023 | -$0.14 | $0 | |||
05/15/2023 | Q1 2023 | -$0.34 | $0 | |||
03/15/2023 | Q4 2022 | -$0.16 | $0 | |||
11/09/2022 | Q3 2022 | -$0.28 | -$0.23 | 0.05 | $0 | |
08/09/2022 | Q2 2022 | -$0.74 | -$0.51 | 0.23 | $0 | |
05/10/2022 | Q1 2022 | -$0.55 | -$0.71 | -0.16 | $0 | |
03/01/2022 | Q4 2021 | -$0.65 | -$0.79 | -0.14 | $0 | |
10/29/2021 | Q3 2021 | -$0.74 | -$0.73 | 0.01 | $0 | |
08/06/2021 | Q2 2021 | -$0.76 | -$0.74 | 0.02 | $0 | |
05/06/2021 | Q1 2021 | -$0.72 | -$0.78 | -0.06 | $0 | |
03/01/2021 | Q4 2020 | -$0.73 | -$0.70 | 0.03 | $0 | |
11/12/2020 | Q3 2020 | -$0.62 | -$0.73 | -0.11 | $0 | |
08/14/2020 | Q2 2020 | -$0.62 | -$0.60 | 0.02 | $0 | |
05/12/2020 | Q1 2020 | -$0.44 | -$0.61 | -0.17 | $0 | |
03/16/2020 | Q4 2019 | -$0.40 | -$0.46 | -0.06 | $0 | |
11/12/2019 | Q3 2019 | -$0.37 | -$0.37 | 0 | $0 |
Quince Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Quince Therapeutics, Inc.'s earnings date?
Quince Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did Quince Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Quince Therapeutics, Inc. (:QNCX) reported $-0.22 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.28 by $0.06.
-
How can I listen to Quince Therapeutics, Inc.'s earnings conference call?
The conference call for Quince Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Quince Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Quince Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Quince Therapeutics, Inc. generate each year?
Quince Therapeutics, Inc. (:QNCX) has a recorded net income of $0. Quince Therapeutics, Inc. has generated $-0.84 earnings per share over the last four quarters.
-
What is Quince Therapeutics, Inc.'s price-to-earnings ratio?
Quince Therapeutics, Inc. (:QNCX) has a price-to-earnings ratio of -0.64 and price/earnings-to-growth ratio is -0.01.